A detailed history of Advisors Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisors Capital Management, LLC holds 555,177 shares of ABBV stock, worth $94.5 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
555,177
Previous 545,966 1.69%
Holding current value
$94.5 Million
Previous $93.6 Million 17.08%
% of portfolio
1.78%
Previous 1.63%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.51 Million - $1.84 Million
9,211 Added 1.69%
555,177 $110 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $3.12 Million - $3.65 Million
20,174 Added 3.84%
545,966 $93.6 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $3.76 Million - $4.28 Million
23,518 Added 4.68%
525,792 $95.7 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $707,676 - $797,010
5,143 Added 1.03%
502,274 $77.8 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $2.05 Million - $2.37 Million
15,353 Added 3.19%
497,131 $74.1 Million
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $806,853 - $1 Million
-6,089 Reduced 1.25%
481,778 $64.9 Million
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $385,096 - $443,496
2,663 Added 0.55%
487,867 $77.8 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $2.44 Million - $2.93 Million
-17,640 Reduced 3.51%
485,204 $78.4 Million
Q3 2022

Nov 16, 2022

BUY
$134.21 - $153.93 $1.47 Million - $1.69 Million
10,979 Added 2.23%
502,844 $76.3 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $714,523 - $908,392
-5,192 Reduced 1.04%
491,865 $75.3 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $1.1 Million - $1.36 Million
8,333 Added 1.71%
497,057 $80.6 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $8.32 Million - $10.5 Million
77,415 Added 18.82%
488,724 $66.2 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $1.99 Million - $2.26 Million
18,720 Added 4.77%
411,309 $44.4 Million
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $311,947 - $347,527
2,965 Added 0.76%
392,589 $44.2 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $12.9 Million - $14.2 Million
126,047 Added 47.82%
389,624 $42.2 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $733,666 - $990,527
9,115 Added 3.58%
263,577 $28.2 Million
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $47,250 - $55,456
-550 Reduced 0.22%
254,462 $22.3 Million
Q2 2020

Aug 18, 2020

BUY
$73.37 - $98.18 $18.1 Million - $24.2 Million
246,781 Added 2998.19%
255,012 $25 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $281,155 - $426,266
4,359 Added 112.58%
8,231 $627,000
Q4 2019

Jan 10, 2020

BUY
$72.13 - $90.25 $279,287 - $349,448
3,872 New
3,872 $343,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Advisors Capital Management, LLC Portfolio

Follow Advisors Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.